Metraipolis › archive › dc_4c932134aedc

Baseline Characteristics of the TOPaZ Study: Randomised Trial of Teriparatide and Zoledronic Acid Compared with Standard Care in Adults with Osteogenesis… — Europe PMC PMID:41206390

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41206390
DOI: 10.1007/s00223-[numero omesso]-3
License (as archived): solo-consultazione
Archived: 2026-11-08T17:24:54.757Z
SHA-256 of the archived text: ace66800913085f39131a570a441d3faf8d4ae590b972f725d208b70d5ab863e
Stable URL of this page: https://metraipolis.com/documento/dc_4c932134aedc

How to cite

Baseline Characteristics of the TOPaZ Study: Randomised Trial of Teriparatide and Zoledronic Acid Compared with Standard Care in Adults with Osteogenesis… — Europe PMC PMID:41206390 — Europe PMC (en), https://europepmc.org/article/MED/41206390 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4c932134aedc (Metraipolis archive dc_4c932134aedc, sha256 ace66800913085f39131a570a441d3faf8d4ae590b972f725d208b70d5ab863e)

BibTeX

@misc{dc4c932134aedc,
  title = {Baseline Characteristics of the TOPaZ Study: Randomised Trial of Teriparatide and Zoledronic Acid Compared with Standard Care in Adults with Osteogenesis… — Europe PMC PMID:41206390},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41206390},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4c932134aedc; sha256 ace66800913085f39131a570a441d3faf8d4ae590b972f725d208b70d5ab863e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41206390. Agents can read the archived copy with the MCP tool read_document.